| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-06 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.12 | 2e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.12 | 4e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |